Literature DB >> 33393982

The Future Is P-Tau-Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests.

Emily A Largent1, Anna Wexler1, Jason Karlawish1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33393982      PMCID： PMC8035155          DOI： 10.1001/jamaneurol.2020.4835

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  6 in total

1.  "A private little revolution": the home pregnancy test in American culture.

Authors:  Sarah Leavitt
Journal:  Bull Hist Med       Date:  2006       Impact factor: 1.314

2.  The Proactive Patient: Long-Term Care Insurance Discrimination Risks of Alzheimer's Disease Biomarkers.

Authors:  Jalayne J Arias; Ana M Tyler; Benjamin J Oster; Jason Karlawish
Journal:  J Law Med Ethics       Date:  2018-06       Impact factor: 1.718

3.  Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.

Authors:  Sebastian Palmqvist; Shorena Janelidze; Yakeel T Quiroz; Henrik Zetterberg; Francisco Lopera; Erik Stomrud; Yi Su; Yinghua Chen; Geidy E Serrano; Antoine Leuzy; Niklas Mattsson-Carlgren; Olof Strandberg; Ruben Smith; Andres Villegas; Diego Sepulveda-Falla; Xiyun Chai; Nicholas K Proctor; Thomas G Beach; Kaj Blennow; Jeffrey L Dage; Eric M Reiman; Oskar Hansson
Journal:  JAMA       Date:  2020-08-25       Impact factor: 56.272

4.  Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results.

Authors:  Emily A Largent; Kristin Harkins; Christopher H van Dyck; Sara Hachey; Pamela Sankar; Jason Karlawish
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

5.  Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors.

Authors:  Jill S Goldman; Susan E Hahn; Jennifer Williamson Catania; Susan LaRusse-Eckert; Melissa Barber Butson; Malia Rumbaugh; Michelle N Strecker; J Scott Roberts; Wylie Burke; Richard Mayeux; Thomas Bird
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822

6.  Desire for predictive testing for Alzheimer's disease and impact on advance care planning: a cross-sectional study.

Authors:  Meera Sheffrin; Irena Stijacic Cenzer; Michael A Steinman
Journal:  Alzheimers Res Ther       Date:  2016-12-13       Impact factor: 6.982
  6 in total
  4 in total

Review 1.  Rapidly Progressive Dementia.

Authors:  Gregory S Day
Journal:  Continuum (Minneap Minn)       Date:  2022-06-01

Review 2.  Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility.

Authors:  Thomas K Karikari; Nicholas J Ashton; Gunnar Brinkmalm; Wagner S Brum; Andréa L Benedet; Laia Montoliu-Gaya; Juan Lantero-Rodriguez; Tharick Ali Pascoal; Marc Suárez-Calvet; Pedro Rosa-Neto; Kaj Blennow; Henrik Zetterberg
Journal:  Nat Rev Neurol       Date:  2022-05-18       Impact factor: 44.711

3.  Plasma p-tau181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau.

Authors:  Brandon Frank; Madeline Ally; Bailee Brekke; Henrik Zetterberg; Kaj Blennow; Michael A Sugarman; Nicholas J Ashton; Thomas K Karikari; Yorghos Tripodis; Brett Martin; Joseph N Palmisano; Eric G Steinberg; Irene Simkina; Katherine W Turk; Andrew E Budson; Maureen K O'Connor; Rhoda Au; Lee E Goldstein; Gyungah R Jun; Neil W Kowall; Thor D Stein; Ann C McKee; Ronald Killiany; Wei Qiao Qiu; Robert A Stern; Jesse Mez; Michael L Alosco
Journal:  Alzheimers Dement       Date:  2021-12-02       Impact factor: 16.655

4.  Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society.

Authors:  Claire M Erickson; Lindsay R Clark; Fred B Ketchum; Nathaniel A Chin; Carey E Gleason; Emily A Largent
Journal:  Alzheimers Dement (Amst)       Date:  2022-08-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.